Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
MyChesCo on MSN1d
Globus Medical to Acquire Nevro Corp. in Strategic $250 Million DealGlobus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of Nevro Corp. (NYSE: NVRO) in an ...
The days of trailers and demos are done as the ESA broadens its horizons. The newly minted “iicon” conference will bring ...
Jefferies analyst reiterated a Buy rating for Globus Medical (NYSE:GMED), with a steady price target of $105.00, following the company's announcement of its plans to acquire Nevro Corp . (NYSE:NVRO), ...
Sumitomo (SHI) Demag Plastics Machinery GmbH (Booth 4239) will present its Robot SAM-C series for the first time in North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback